Borrelia burgdorferi Outer Surface Protein a (OspA) Activates and Primes Human Neutrophils

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 4838-4845

  Morrison, Tom B ^a   Weis, John H ^a   Weis, Janis J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; CD11B ANTIGEN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 8; L SELECTIN; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDE; LIPOPROTEIN; MEMBRANE ANTIGEN; MEMBRANE METALLOENDOPEPTIDASE; OUTER MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A; SUPEROXIDE;

ARTICLE; BIOSYNTHESIS; BORRELIA BURGDORFERI; CELL ADHESION; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; IMMUNOLOGY; METABOLISM; NEUTROPHIL; RESPIRATORY BURST; TIME;

ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; CELL ADHESION; EXTRACELLULAR MATRIX; HUMANS; INTERLEUKIN-8; L-SELECTIN; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MACROPHAGE-1 ANTIGEN; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEPRILYSIN; NEUTROPHILS; RESPIRATORY BURST; SUPEROXIDES; TIME FACTORS;

EID: 0031570026     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Burgdorfer, W., A. O. Barbour, S. F. Hayes, J. L. Benach, E. Grunwaldt, and J. P. Davis. 1982. Lyme disease: a tick-borne spirochetosis? Science 216:1317.
2. Lyme disease: United States, 1994. 1995. Morb. Mortal. Wkly. Rep. 44:459.
3. Nocton, J. J., and A. C. Steere. 1995. Lyme disease. Adv. Intern. Med. 40:69.
4. Barthold, S. W. 1996. Lyme borreliosis in the laboratory mouse. J. Spirochetal Tick-Borne Dis. 3:22.
5. Nocton, J. J., F. Dressler, B. J. Rutledge, P. N. Rys, D. H. Persing, and A. C. Steere. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330: 229.
6. Yang, L., J. H. Weis, E. Eichwald, C. P. Kolbert, D. H. Persing, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:492.
7. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peoples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263.
8. Barthold, S. W., C. L. Sidman, and A. L. Smith. 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47:605.
9. Pachner, A. R., J. Basta, E. Delaney, and D. Hulinska. 1995. Localization of Borrelia burgdorferi in murine Lyme borreliosis by electron microscopy. Am. J. Trop. Med. Hyg. 52:128.
10. Seiler, K. P., Z. Vavrin, E. Eichwald, J. Hibbs, Jr., and J. J. Weis. 1995. Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology. Infect. Immun. 63:3886.
11. Modolell, M., U. E. Schaible, M. Rittig, and M. M. Simon. 1994. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol. Lett. 40:139.
12. Cinco, M., R. Murgia, S. Perticarari, and G. Presani. 1994. Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. FEMS Microbiol. Lett. 122:187.
13. Montgomery, R. R., and S. E. Malawista. 1996. Entry of Borrelia burgdorferi into macrophages is end-on and leads to degradation in lysosomes. Infect. Immun. 64:2867.
14. Montgomery, R. R., M. H. Nathanson, and S. E. Malawista. 1993. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages: destruction, survival, recovery. J. Immunol. 150:909.
15. Rittig, M. G., A. Krause, T. Haupl, U. E. Schaible, M. Modolell, M. D. Kramer, E. Lutjen-Drecoll, M. M. Simon, and G. R. Burmester. 1992. Coiling phagocytosis is the preferential phagocytic mechanism for Borrelia burgdorferi. Infect. Immun. 60:4205.
16. Montgomery, R. R., M. H. Nathanson, and S. E. Malawista. 1994. Fc- and non-Fc-mediated phagocytosis of Borrelia burgdorferi by macrophages. J. Infect. Dis. 170:890.
17. Peterson, P. K., C. C. Clawson, D. A. Lee, D. J. Garlich, P. G. Quie, and R. C. Johnson. 1984. Human phagocyte interactions with the Lyme disease spirochete. Infect. Immun. 46:608.
18. Georgilis, K., A. C. Steere, and M. S. Klempner. 1991. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J. Infect. Dis. 163:150.
19. Barthold, S. W., and S. M. de. 1995. Exacerbation of Lyme arthritis in beige mice. J. Infect. Dis. 172:778.
20. Ribeiro, J. M., J. J. Weis, and S. R. Telford, III. 1990. Saliva of the tick Ixodes dammini inhibits neutrophil function. Exp. Parasitol. 70:382.
21. 2-dependent mechanism. J. Exp. Med. 180:1077.
22. Schaible, U. E., S. Gay, C. Museteanu, M. D. Kramer, G. Zimmer, K. Eichmann, U. Museteanu, and M. M. Simon. 1990. Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. Am. J. Pathol. 137:811.
23. Takayama, K., R. J. Rothenberg, and A. G. Barbour. 1987. Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 55:2311.
24. Wooten, R. M., V. R. Modur, T. M. McIntyre, and J. J. Weis. 1996. Borrelia burgdorferi outer membrane protein A induces nuclear translocation of nuclear factor-κB and inflammatory activation in human endothelial cells. J. Immunol. 157:4584.
25. Schoenfeld, R., B. Araneo, Y. Ma, L. M. Yang, and J. J. Weis. 1992. Demonstration of a B-lymphocyte mitogen produced by the Lyme disease pathogen, Borrelia burgdorferi. Infect. Immun. 60:455.
26. Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866.
27. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843.
28. Radolf, J. D., M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson, and B. Beutler. 1991. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis: analysis using a CAT reporter construct. J. Immunol. 147:1968.
29. Honarvar, N., U. E. Schaible, C. Galanos, R. Wallich, and M. M. Simon. 1994. A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology 82:389.
30. Weis, J. J., Y. Ma, and L. F. Erdile. 1994. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632.
31. De Souza, M. S., E. Fikrig, A. L. Smith, R. A. Flavell, and S. W. Barthold. 1992. Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J. Infect. Dis. 165:471.
32. Tai, K. F., Y. Ma, and J. J. Weis. 1994. Normal human B lymphocytes and mononuclear cells respond Io the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect. Immun. 62:520.
33. Erdile, L. F., M. A. Brandt, D. J. Warakomski, G. J. Westrack, A. Sädziene, A. G. Barbour, and J. P. Mays. 1993. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect. Immun. 61:81.
34. Bouchon, B., A. Van Dorsselaer, and C. Roitsch. 1993. Characterization of multiple acylation sites on a recombinant protein by electrospray mass spectrometry. Biol. Mass Spectrum. 22:358.
35. Dunn, J. J., B. N. Lade, and A. G. Barbour. 1990. Outer surface protein A (OspA) from the Lyme disease spirochete. Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr. Purif. 1:159.
36. Zimmerman, G. A., T. M. McIntyre, and S. M. Prescott. 1985. Thrombin stimulates the adherence of neutrophils to human endothelial cells in vitro. J. Clin. Invest. 76:2235.
37. Smiley, P. L., K. E. Stremler, S. M. Prescott, G. A. Zimmerman, and T. M. Mclntyre. 1991. Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor. J. Biol. Chem. 266: 11104.
38. Hornbeck, P. 1991. Assays for Antibody Production. John Wiley & Sons. New York.
39. Powers, J. C., and B. F. Gupton. 1977. Reaction of serine proteases with aza-amino acid and aza-peptide derivatives. Methods Enzymol. 46:208.
40. Weingarten, R., L. A. Sklar, J. C. Mathison, S. Omidi, T. Ainsworth, S. Simon, R. J. Ulevitch, and P. S. Tobias. 1993. Interactions of lipopolysaccharide with neutrophils in blood via CD14. J. Leukocyte Biol. 53:518.
41. Kishimoto, T. K., M. A. Jutila, E. L. Berg, and E. C. Butcher. 1989. Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245:1238.
42. Hailman, E., T. Vasselon, M. Kelley, L. A. Busse, M. C.-T. Hu, H. S. Lichenstein, P. A. Detmers, and S. D. Wright. 1996. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. J. Immunol. 156:4384.
43. Borregaard, N., L. Kjeldsen, K. Lollike, and H. Sengelov. 1995. Granules and secretory vesicles of the human neutrophil. Clin. Exp. Immunol. 101:6.
44. Shipp, M. A., G. B. Stefano, S. N. Switzer, J. D. Griffin, and E. L. Reinherz. 1991. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 78:1834.
45. Fagny, C., A. Marchant, E. De Prez, M. Goldman, and M. Deschodt-Lanckman. 1995. Lipopolysaccharide induces upregulation of neutral endopeptidase 24.11 on human neutrophils: involvement of the CD14 receptor. Clin. Sci. 89:83.
46. Wright, S. D., R. A. Ramos, A. Hermanowski-Vosatka, P. Rockwell, and P. A. Detmers. 1991. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J. Exp. Med. 173:1281.
47. Fujishima, S., and N. Aikawa. 1995. Neutrophil-mediated tissue injury and its modulation. Intensive Core Med. 21:277.
48. Guthrie, L. A., L. C. McPhail, P. M. Henson, and R. B. Johnston, Jr. 1984. Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide: evidence for increased activity of the superoxide-producing enzyme. J. Exp. Med. 160:1656.
49. Forehand, J. R., M. J. Pabst, W. A. Phillips, and R. B. Johnston, Jr. 1989. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst: role of intracellular free calcium. J. Clin. Invest. 83:74.
50. Babior, B. M. 1984. The respiratory burst of phagocytes. J. Clin. Invest. 73:599.
51. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301.
52. Tedder, T. F., D. A. Steeber, A. Chen, and P. Engel. 1995. The selectins: vascular adhesion molecules. FASEB J. 9:866.
53. Kuijpers, T. W., A. T. Tool, C. E. van der School, L. A. Ginsel, J. J. Onderwater, D. Roos, and A. J. Verhoeven. 1991. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 78:1105.
54. Liou, T. G., and E. J. Campbell. 1996. Quantum proteolysis resulting from release of single granules by human neutrophils. J. Immunol. 157:2624.
55. Seifert, R., G. Schultz, M. Richter-Freund, J. Metzger, K. H. Wiesmuller, G. Jung, W. G. Bessler, and S. Hauschildt. 1990. Activation of Superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides. Biochem. J. 267:795.
56. de Silva, A. M., S. R. Telford, III, L. R. Brunei, S. W. Barthold, and E. Fikrig. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271.
57. Barthold, S. W., E. Fikrig, L. K. Bockenstedt, and D. H. Persing. 1995. Circumvention of outer surface protein A immunity by host-adapted Borrelia burgdorferi. Infect. Immun. 63:2255.
58. Schwan, T. G., J. Piesman, W. T. Golde, M. C. Dolan, and P. A. Rosa. 1995. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl. Acad. Sci. USA 92:2909.
59. Fikrig, E., S. W. Barthold, and R. A. Flavell. 1993. OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect. Immun. 61:2553.
60. Burkot, T. R., J. Piesman, and R. A. Wirtz. 1994. Quantitation of the Borrelia burgdorferi outer surface protein A in Ixodes scapularis: fluctuations during the tick life cycle, doubling times, and loss while feeding. J. Infect. Dis. 170:883.
61. Golde, W. T., and M. C. Dolan. 1995. Variation in antigenicity and infectivity of derivatives of Borrelia burgdorferi, strain B31, maintained in the natural, zoonotic cycle compared with maintenance in culture. Infect. Immun. 63:4795.
62. Kalish, R. A., J. M. Leong, and A. C. Steere. 1993. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi. Infect. Immun. 61:2774.
63. Suk, K., S. Das, W. Sun, B. Jwang, S. W. Barthold, R. A. Flavell, and E. Fikrig. 1995. Borrelia burgdorferi genes selectively expressed in the infected host. Proc. Natl. Acad. Sci. USA 92:4269.
64. Champion, C. I., D. R. Blanco, J. T. Skare, D. A. Haake, M. Giladi, D. Foley, J. M. Miller, and M. A. Lovett. 1994. A 9.0-kilobase-pair circular plasmid of Borrelia burgdorferi encodes an exported protein: evidence for expression only during infection. Infect. Immun. 62:2653.
65. Ramamoorthy, R., L. Povinelli, and M. T. Philipp. 1996. Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi. Infect. Immun. 64:1259.
66. Wallich, R., C. Brenner, M. D. Kramer, and M. M. Simon. 1995. Molecular cloning and immunological characterization of a novel linear-plasmid-encoded gene, pG, of Borrelia burgdorferi expressed only in vivo. Infect. Immun. 63: 3327.
67. Akins, D. R., S. F. Porcella, T. G. Popova, D. Shevchenko, S. I. Baker, M. Li, M. V. Norgard, and J. D. Radolf. 1995. Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue. Mol. Microbiol. 18:507.
68. Montgomery, R. R., S. E. Malawista, K. J. M. Feen, and L. K. Bockenstedt. 1996. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease. J. Exp. Med. 183:261.
69. Defosse, D. L., and R. C. Johnson. 1992. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect. Immun. 60:1109.
70. Yang, L., Y. Ma, R. Schoenfeld, M. Griffiths, E. Eichwald, B. Araneo, and J. J. Weis. 1992. Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect. Immun. 60:3033.
71. Zoschke, D. C., A. A. Skemp, and D. L. Defosse. 1991. Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease. Ann. Intern. Med. 114:285.
72. Hurtenbach, U., C. Museteanu, J. Gasser, U. E. Schaible, and M. M. Simon. 1995. Studies on early events of Borrelia burgdorferi-induced cytokine production in immunodeficient SCID mice by using a tissue chamber model for acute inflammation. Int. J. Exp. Palhol. 76:111.
73. Whitmire, W. M., and C. F. Garon. 1994. Induction of B-cell mitogenesis by outer surface protein C of Borrelia burgdorferi. J. Spirochetal Tick-Borne Dis. 1:64.
74. Hauschildt, S., P. Hoffmann, H. U. Beuscher, G. Dufhues, P. Heinrich, K. Weismuller, G. Jung, and W. G. Bessler. 1990. Activation of hone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur. J. Immunol. 20:63.
75. Bessler, W. G., M. Cox, A. Lex, B. Suhr, K. H. Wiesmuller, and G. Jung. 1985. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes. J. Immunol. 135:1900.
76. Prass, W., H. Ringsdorf, W. Bessler, K. H. Wiesmuller, and G. Jung. 1987. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments. Biochim. Biophys. Acta 900: 116.
77. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
78. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509.
79. Norgard, M. V., L. L. Arndt, D. R. Akins, L. L. Curetty, D. A. Harrich, and J. D. Radolf. 1996. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves transcriptional activator NF-κB. Infect. Immun. 64:3845.
80. Sellati, T. J., L. D. Abrescia, J. D. Radolf, and M. B. Furie. 1996. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect. Immun. 64:3180.
81. Sellati, T. J., M. J. Burns, M. A. Ficazzola, and M. B. Furie. 1995. Borrelia burgdorferi upregulates expression of adhesion molecules on endothelial cells and promotes transendothelial migration of neutrophils in vitro. Infect. Immun. 63:4439.